The evolution of drug-resistant microbial species is one of the major challenges to global health. The development of new antimicrobial treatments such as antimicrobial peptides needs to be accelerated to combat this threat. However, the discovery of novel antimicrobial peptides is hampered by low-throughput biochemical assays. Computational techniques can be used for rapid screening of promising antimicrobial peptide candidates prior to testing in the wet lab. The vast majority of existing antimicrobial peptide predictors are non-targeted in nature, i.e., they can predict whether a given peptide sequence is antimicrobial, but they are unable to predict whether the sequence can target a particular microbial species. Results: In this work, we have developed a targeted antimicrobial peptide activity predictor that can predict whether a peptide is effective against a given microbial species or not. This has been made possible through zero-shot and few-shot machine learning. The proposed predictor called AMP0 takes in the peptide amino acid sequence and any N/C-termini modifications together with the genomic sequence of a target microbial species to generate targeted predictions. It is important to note that the proposed method can generate predictions for species that are not part of its training set. The accuracy of predictions for novel test species can be further improved by providing a few example peptides for that species. Our computational cross-validation results show that the proposed scheme is particularly effective for targeted antimicrobial prediction in comparison to existing approaches and can be used for screening potential antimicrobial peptides in a targeted manner especially for cases in which the number of training examples is small. Availability: We have also developed a webserver of the proposed methodology available at
Introduction
Antibiotics play a significant role in protecting humans from microbial infections. The discovery and use of antibiotics since the 1930s has helped in treating serious infections and saved many lives (Aslam et al., 2018) . (Blair, 2018; Ventola, 2015) . Resistance against antibiotics in microbes was detected in the 1960s and it prompted an evolutionary arms race between microbes and antibiotics (Ventola, 2015) . Antimicrobial resistance is currently a major global health crisis. The number of deaths due to infections caused by antibiotic resistance annually is increasing and is estimated to reach up to 10 million by 2050 (Blair, 2018) . World Health Organization (WHO) has generated a list of antibiotic resistant bacterial species that are a major threat to global health and require urgent development of novel therapeutics against them: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter (Lakemeyer et al., 2018) . To handle the issue of antibiotic resistance, the development of novel antibiotics is necessary (Aslam et al., 2018; Blair, 2018; Ventola, 2015; Lakemeyer et al., 2018; Spaulding et al., 2018) . In comparison to the rate of development of antimicrobial resistance, the pace of discovery or development of new antibiotics is very slow: in the last 2 decades only two new classes of antibiotics were introduced for clinical use (Lakemeyer et al., 2018) . Consequently, the use of vaccines, lysins, antibodies, probiotics, bacteriophages and antimicrobial peptides (AMPs) is becoming popular in therapeutics as alternatives to antibiotics (Aslam et al., 2018) . For designing new drugs, the use of AMPs is rapidly gaining attention (Aslam et al., 2018; Kampshoff et al., 2019; Costa et al., 2019; Yu et al., 2018) . AMPs exhibit different biological activities against microbes, e.g., bacteria, viruses, fungi, etc. (Aslam et al., 2018) , have higher inhibition rates than antibiotics, and can potentially slow down the evolution of antibiotic resistance as well (Yu et al., 2018) . Potential AMP candidates need to be tested and evaluated experimentally before entering clinical trials. The prediction of AMPs using machine learning techniques reduces the cost of identifying the effectiveness of a peptide sequence against microbial species in the wet lab by prescreening potential antimicrobial peptides. A number of machine learning based AMP predictors are available in the literature (Gull et al., 2019; Bhadra et al., 2018; Torrent et al., 2009; Waghu et al., 2015; Lin and Xu, 2016; Agrawal and Raghava, 2018) . The primary issue with these un-targeted predictors is that they are unable to predict whether a given peptide sequence will be effective against a given target microbial species or not (see Fig 1) . Only a small number of targeted predictors exist in the literature but they are not able to generate predictions for novel microbial species (Kleandrova et al., 2016; Vishnepolsky et al., 2018; Speck-Planche et al., 2016) . Vishnepolsky et al. developed a predictor for 6 different gram-negative bacterial strains (Vishnepolsky et al., 2018) . The AMP predictor by Kleandrova et al. used 70 different gramnegative strains of bacteria in training to predict antimicrobial and cytotoxic activity of individual amino acids in a peptide sequence for different strains (Kleandrova et al., 2016) . Although they covered a large set of bacterial species, their method can generate predictions for only specific strains of gram-negative bacterial strains. Unavailability of their predictor for public use is also a limitation (Kleandrova et al., 2016) . The major drawback in targeted predictors is their inability of predicting a (Coordinators, 2016) 8,025
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peptide's antimicrobial activity for novel microbial species. The prediction of antimicrobial activity of a peptide without knowing the microbial species against which the peptide is effective is not meaningful.
In this work, we have developed a machine learning model to overcome this limitation. The proposed model takes amino acid sequence of a peptide and the genomic sequence of a target microbial species to predict the effectiveness of the peptide against that species in a targeted manner.
Methods

Data collection and preprocessing
For constructing the dataset used for training and evaluation of our machine learning models, we have used DBAASP version 2 (Pirtskhalava et al., 2015) . DBAASP has been widely used in recent studies in this field (Kleandrova et al., 2016; Youmans et al., 2017; Vishnepolsky et al., 2018; Speck-Planche et al., 2016; Win et al., 2017) . It contains a total of 12, 984 peptide sequences and their experimentally verified minimum inhibitory concentrations (MICs) against various target microbial species. In order to construct our dataset from DBAASP, we have used peptides with length greater than 5 amino acids whose experimentally validated MICs are available in micro molar ( ) or microgram per milliliter ( / ). We also ensured that the genomes of the target species are available in NCBI (Coordinators, 2016) and that each peptide in our dataset has at least one target species for which its MIC was ≤ 25 / (Vishnepolsky et al., 2018) . The details of different filtration stages to extract the dataset of our interest are given in Table- 1. DBAASP reports the effectiveness of a peptide sequence against multiple strains of a microbial species. We have taken the minimum MIC of a peptide across different strains of a species as its MIC against that species. All MIC values have been converted to / (Kleandrova et al., 2016) . Our final dataset comprises of 5,710 peptides that are effective against a total of 336 different microbial species. The details of individu- MICs converted to continuous labels between -1 to +1 using bipolar sigmoid function al peptides and their MICs against their target species is given in supplementary material.
As an additional preprocessing step, we have scaled the MIC scores using a sigmoidal curve such that MIC scores ≤ 25 / are mapped onto +1 and those ≥ 100 / are mapped to -1 (see Fig. 2 ). For this purpose, we have utilized a sigmoid rescaling function which maps raw MIC scores as follows:
This rescaling ensures that subsequent processing and machine learning models are not affected by large variations in MICs across different target species and peptides which can vary from a few / to more than 2000 / . If the MIC of a peptide is not known for a species, its rescaled score is set at 0.0.
Feature extraction
To predict antimicrobial activity of a peptide against given species through machine learning, we need features of peptide and genomic sequence of target microbial species as discussed below (see Fig. 3 ).
Amino Acid Sequence features
In order to obtain peptide-level features, we have used one-hot encoding of the peptide sequence that results in a 40-dimensional feature vector (frequency count of 20 L-amino acids and 20 D-amino acids). The feature representation models the type of amino acid (L and D) in the peptide sequence separately as peptide bioactivity is dependent upon the type of amino acids (Cava et al., 2011; Mangoni et al., 2006; Baltz, 2009; Kawai et al., 2004) . The resulting feature vectors for a given peptide is normalized to unit norm. We have also analyzed 2-mer composition which results in a 40 2 = 1600-dimensional feature vector (Leslie et al., 2001) . DBAASP (Pirtskhalava et al., 2015) also provides information about Nterminus and C-terminus modifications of peptides which can play a significant role in their antimicrobial activity. Modification at Nterminus and C-terminus of peptides can change their biological activity (Crusca Jr et al., 2011) . We have used one-hot encoding to capture information about C-and N-terminus modifications in our feature representation. The sequence features are concatenated with C and N termini features. Details about the different types of C and N termini modifications are given in supplementary information.
Genomic features
In order to perform targeted prediction of antimicrobial activity of a peptide sequence against a particular species through machine learning, we need to extract species-level features as well. The literature reports the use of mono, di, tri and tetra-nucleotide composition of genomic sequences for comparison or clustering of genomes (Karlin and Ladunga, 1994; Kariin and Burge, 1995; Nakashima et al., 1997 Nakashima et al., , 1998 Pride et al., 2003; Takahashi et al., 2009) . As a consequence, we have extracted features from complete genomes of species downloaded from NCBI (Coordinators, 2016) . For feature extraction the counts of 1-mer, 2-mer, 3-mer and 4-mer are calculated from a given genome sequence and normalized to unit norm resulting in a 340-dimensional feature representation.
Prediction Models
To predict whether a given peptide sequence will be effective against a target microbial species or not, we have proposed a zero-shot machine learning model. We compare the proposed model to a conventional ma chine learning model as a baseline as discussed below. In order to aid the reader in understanding our modeling approach for baseline and zeroshot predictors, we denote a peptide sequence by its d-dimensional feature vector , = 1, … , 5710 whereas a particular microbial species is represented by an a-dimensional attribute vector , for = 1, … , 336 based on its genomic sequence. We denote the rescaled MIC of a peptide against species by the target variable . The prediction problem can then be expressed as finding a mathematical function ( , ; ) parameterized by learnable parameters that can predict the effectiveness of a sequence for microbial species .
Baseline models
We have chosen Radial Basis Function SVM (Cortes and Vapnik, 1995) and XGBoost (Chen and Guestrin, 2016) as baseline models due to their widespread use and ease of modeling. For this purpose, in order to predict the effectiveness of a given peptide sequence against a microbial species, we construct a joint feature representation = [ ] by concatenating peptide and species level features with the associated training label set to +1 (antimicrobial) if the MIC of peptide for species is ≤ 25 / and -1 (non-antimicrobial) if the MIC is ≥ 100 / . A conventional SVM or XGBoost model can then be trained over such a data set.
Zero and Few shot learning
In this work, we propose to model the problem of targeted antimicrobial activity prediction through zero shot learning (ZSL) (Romera-Paredes and Torr, 2015) . Widely used in object classification and computer vision, ZSL allows a classification model to generate predictions for novel classes which were not available at training time (Socher et al., 2013; Norouzi et al., 2013; Fu et al., 2015) . This is achieved by learning the definition of a class through an attribute vector representation instead of predicting class labels directly as in conventional classification. Many variants of ZSL have been proposed in the literature (Palatucci et al., 2009; Zhang and Saligrama, 2015; Socher et al., 2013; Norouzi et al., 2013; Fu et al., 2015; Kodirov et al., 2017; Romera-Paredes and Torr, 2015) . While ZSL assumes that no examples of a novel class presented during testing are available for training, the related case of few-shot learning aims at building a machine learning model such that only a few training examples are available for the target class (Snell et al., 2017; Sung et al., 2018; Gidaris and Komodakis, 2018; Garcia and Bruna, 2017; Ravi and Larochelle, 2016) . Few Shot Learning (FSL) techniques perform significantly better than conventional classification methods when the number of training examples is very small (Snell et al., 2017; Sung et al., 2018; Gidaris and Komodakis, 2018) .
The problem of targeted antimicrobial activity prediction is ideally suited to zero and few shot learning: in typical machine learning guided design of wet lab experiments for screening potential peptides that are effective against a target microbial species, no or very few peptides with known labels are available for training. Furthermore, in order to predict how effective a peptide is against a novel microbial species for which no or very few training examples are available, we can model the target microbial species as a class represented by an attribute vector based on its genomic sequence. In this work, we have used the ZSL scheme given by Romera-Paredes and Torr (Romera-Paredes and Torr, 2015) . For predicting the MIC of a peptide sequence for a target species, the discriminant function used by the ZSL model of Romera-Paredes and Torr (Romera-Paredes and Torr, 2015) can be written as ( , ; ) = with the learnable weight matrix ∈ ℝ × . If the number of peptides and species (classes) available during training are and , respectively and the rescaled MIC scores for each of the peptide against each microbe is represented by the × matrix ∈ [−1,1] × , the learning problem for ZSL can be formulated as the following optimization problem:
Here, ∈ ℝ × and ∈ ℝ × represent matrices of all peptide features ( examples each with a -dimensional feature vector) and attributes of microbial species ( classes each with attributes), respectively. The first term represents the loss function with the aim of minimizing the error between predicted and target MICs. The second term ( ‖ ‖ 2 + ‖ ‖ 2 + ‖ ‖ 2 ) is the regularization factor that ensures smoothness of the prediction function ( , ; ) and sparsity of the weight matrix through penalization of the Frobenius norm ‖•‖ 2 of respective matrices. and are regularization hyper-parameters. In addition to better performance over benchmark datasets, another reason for choosing this ZSL implementation is the existence of a computationally efficient closed-form solution of its underlying optimization problem which can be written as follows: * = ( + ) − ( + ) − Once the optimal weight matrix * has been obtained, the predictions for a peptide (represented by the feature vector ) for species (represented by the attribute vector ) can be generated by the decision function ( , ; * ) = * . Note that this decision function can be used for generating predictions both for novel peptides and novel species provided their attribute representation is available. The most likely target species for a given peptide can be identified by simply ranking the resulting decision function scores across a given list of potential target species. This formulation can be kernelized for non-linear kernels as well by applying the Representer theorem to the underlying optimization problem (Romera-Paredes and Torr, 2015) . For this purpose, an × sized kernel matrix with = ( , ) is computed over the training data using a kernel function such as the radial basis function (RBF) ( , ) = (− ‖ − ‖ 2 ) with the hyperparameter > 0. The closed form solution of the kernelized ZSL optimization problem requires calculation of an × sized instance-attribute association matrix from training data as follows (see (Romera-Paredes and Torr, 2015) for details):
For inference or prediction of effectiveness of a peptide represented by a feature vector against a microbial species represented by its attribute vector , an -dimensional vector of kernel scores ( ) = [ ( , ) ( , ) ⋯ ( , )] of the test example with each training example is computed and used in the kernelized prediction function ( , ; ) = ( ) .
It is important to note that this framework extends seamlessly to FSL by simply adding further training instances for a target class. The hyperparameters of the model ( , , ) are tuned through cross-validation. The best performance of the model was found using = 2.0, = 0.0001, and the hyperparameter of RBF kernel is set to 2.0.
Performance evaluation
We consider two practical use-cases of our system: 1) Target Species Ranking (TSR): given a set of microbial species for which labeled peptide sequences are available for training, predict the microbe that is mostlikely to be targeted by a novel peptide sequence and, 2) Peptide Activity Prediction for Novel Species (PAP): predict whether a peptide is effective against a given species or not such that no or very few peptide examples for that species are available during training (i.e., Zero Shot or Few Shot Learning) (see Fig. 4 ). It is important to note that both these scenarios reflect practical use cases for biologists who are interested in machine-learning guided discovery for targeted antimicrobial peptides. In order to evaluate the performance of baseline and proposed machine learning models for TSR, we have used 5-fold cross validation (John Lu, 2010) . The dataset of 5,710 peptides is divided into 5 non-overlapping folds. A given model is trained on labeled examples of all peptides in 4 folds and tested on the remaining peptides. This process is repeated 5 times, once for each fold. For each test peptide in a fold, model scores for all 336 species are sorted in descending order. The rank of the highest scoring microbe that is a known target of the given test peptide (positive example) is used as a peptide-specific performance metric. This simple biologist-centric performance metric called Rank of First Positive Prediction (RFPP) is based on the premise that an ideal machine learning model should assign high score to a known target species of a given peptide sequence and, consequently, rank target species at lower ranks in the sorted list in comparison to non-target species (Minhas et al., 2014) . As a result, for an ideal machine learning model, the RFPP for all test peptides should be 1.0. As discussed in the results section, we report the percentile-wise RFPP scores for all test peptides for different machine learning models together with a random predictor as experimental control. The RFPP score at a certain percentile , henceforth denoted by ( ) is defined as follows: ( ) = , if % test peptides have at least one known target microbial species among their top predictions (out of 336). Thus, for an ideal classifier (100) = 1, i.e., for every (a) (b) Fig 4. (a) PAP takes inputs of a peptide sequence and a novel species genome to predict whether a peptide is effective against a given species or not; (b) TSR requires a novel peptide sequence and predicts the microbe that is most likely to be targeted by that peptide (out of 336 given species)
peptide, the top scoring species is a real target species of the given test peptide. RFPP is a biologist-centric metric as it tells us directly how often top-ranking predictions of a peptide can be expected to correspond to true target species and it can be directly used in experiment design. For PAP, i.e., predicting a peptide's effectiveness for a novel species, our proposed modeling approach takes peptide and genomic sequences as input and the score generated by the decision function of a machine learning model is used for classification of peptide sequences for individual species. In order to quantify predictive accuracy, a selected set of 17 test species from DBAASP with a small but sufficient number (75-180) of known positive and negative peptide examples is used (details given in Table- 2). For ZSL, the model is trained on all examples from other species and its predictive performance is evaluated for individual species in Table 2 using area under the receiver operating characteristic curve (AUC-ROC) as a performance metric (Davis and Goadrich, 2006 
Results
In this section, we discuss the results for the two learning tasks below. Fig 5 shows the percentile-wise RFPP scores for all classifiers. As discussed in section 2.4, the ideal RFPP score for all peptides is 1.0. For the random classifier that generates a random score for a given example, the median RFPP is 75, i.e., for 50% test peptides in cross-validation, a true target species is within the top 75 (out of 336) predictions. In contrast, for XGBoost and SVM baseline models, the median RFPPs are 50 and 10, respectively. However, the proposed model performs much better than these baseline models: the RFPP for the proposed model at the 75 th percentile is 1.0, i.e., the for up to 75% peptides, the top prediction by the model is correct. This clearly shows the effectiveness of the proposed prediction scheme for identifying the correct target species of a peptide. For TSR use case optimal results of SVM and XGBoost were obtained with 2-mer composition features of peptides. Table 2 shows the results of various machine learning models for the Peptide Activity Prediction (PAP) task. In this task the objective is to evaluate whether a given machine learning model can correctly predict peptides that target a novel species for which none or very few training examples are available. For this purpose, we compare the performance of conventional machine learning models (SVM, XGBoost), the proposed Zero Shot Learning (ZSL) and Few Shot Learning (FSL) models in addition to existing state of the art non-targeted antimicrobial activity predictors (CAMP (Waghu et al., 2015) (Gabere and Noble, 2017) and AMAP (Gull et al., 2019) ). For this use case, XGBoost with amino acid composition features performed significantly better than SVM (results not shown for brevity). However, the prediction performance of XGBoost was typically no better than a random classifier especially when the number of training examples from a given test species was very small (see Supplementary Information for complete results) . Similarly, existing state of the art methods such as CAMP (Waghu et al., 2015) and AMAP (Gull et al., 2019) do not give satisfactory predictive performance for the chosen species. In contrast, the proposed few shot learning model performs significantly better than other methods with an expected increase in prediction accuracy when the number of training examples of a species is increased.
Target Species Ranking (TSR)
Peptide Activity Prediction for Novel Species
Webserver and Code
The webserver developed for proposed model together with the code is available at the URL:http://ampzero.pythonanywhere.com. The webserver takes a peptide sequences in FASTA format along with any Cterminus and N-terminus modifications as input together with the genome of a species in order to predict the degree of effectiveness of the peptide against the given species. Additionally, the user can upload a list of known positive and negative example peptide sequences for the given species for generating few shot learning based predictions.
Conclusions
We have developed a targeted antimicrobial activity predictor called AMPZero can predict the effectiveness of a given peptide sequence against a given target species. The use of zero and few shot learning in the proposed model helps in overcoming the shortcomings of conventional machine learning techniques for this purpose. Our cross-validation analysis shows that the proposed model can perform better than existing approaches and it can be easily integrated in experimental discovery of antimicrobial peptide sequences for novel species. 
